Category: news

Pamiparib becomes the first PARP inhibitor approved in both platinum-sensitive and platinum-resistant relapsed ovarian cancer in China This marks the…

BOSTON and LOUISVILLE, Ky., May 06, 2021 (GLOBE NEWSWIRE) — Talaris Therapeutics, Inc., a late-clinical stage cell therapy company developing…

FLORHAM PARK, N.J., May 06, 2021 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused…

CHARLESTON, S.C., May 06, 2021 (GLOBE NEWSWIRE) — Today, Efferent Labs announces an expanded development collaboration with W. L. Gore…

CANTON, Mass., May 06, 2021 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on…

Acquisition of Zikani Therapeutics, Ribosomal Modulation Company; Combined Company Advancing Ribosomal RNA-Targeted Genetic Therapies Additional Treatment Arm Added to Ongoing…

BELTSVILLE, Md., May 06, 2021 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and…

Webcast Today at 4:30 pm Eastern TimeSOUTH SAN FRANCISCO, May 06, 2021 (GLOBE NEWSWIRE) — In a release issued under…

Enrollment ongoing in three Cellectis-sponsored Phase 1 dose-escalation clinical studies BALLI-01 in r/r B-ALL patients, AMELI-01 in r/r AML patients…

PRINCETON, N.J., May 06, 2021 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its…